Giorgia Guglielmi
Giorgia Guglielmi is a freelance science writer based in Basel, Switzerland. Specializing in life sciences, medicine, and the relationship between science and society, she has published numerous articles in outlets including Nature, Science, and Scientific American. She holds a PhD in biology from the European Molecular Biology Laboratory and a Master’s in Science Writing from the Massachusetts Institute of Technology. She has received recognition for her work, including the John Kendrew Award in 2020 and an ERC-funded FRONTIERS Media Fellowship in 2025. She has also led lectures and workshops on science communication at institutions such as Harvard University and the University of Zurich.
The findings of a recent study show that Q-net can accurately predict the long-term trajectories of gut microbes and identify patterns indicative of future cognitive deficits.
The findings of a recent study suggest that the infant gut microbiota begins to develop circadian rhythms soon after birth, with diet having minimal influence on these microbial patterns.
The findings of a recent study reveal how gut bacteria modify immune molecules in ways that lead to the development of IgA nephropathy.
The findings of a recent study suggest that Ruminococcus bacteria were more prevalent in ancient human populations and non-industrialized societies, likely due to the high dietary fiber intake.
The findings of a recent study suggest that the infant microbiota produces neurotransmitters that are required for the development of the immune system.
The results of a recent study suggest that certain dietary changes can counteract bacterial functions that promote disease. The findings thus underscore the importance of examining microbial functions to understand…
The findings of a recent study highlight the importance of considering age-related immune changes and gut microbiota composition for developing personalized immunotherapy approaches.
A recent study demonstrated causation between microbial DCA metabolism and anti-tumor CD8+ T cell response in colorectal cancer.
The findings of a recent study shed light on how the microbiota impacts cholesterol levels. They may also inform microbial-based interventions against high cholesterol.
The findings of a recent study suggest that L. johnsonii or its metabolite IPA could be used as a microbial-based approach to improve a person’s response to immunotherapy.
